She explains that flexible tapering strategies are key to successful antidepressant discontinuation in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care GLP-1 receptor agonists: Optimising nutritional outcomes in primary care Dietitian Sarah MacAvoy explains that while new weight-loss medications show exciting potential, they also put patients at risk of nutritional deficiencies, and dietitian support is essential Kia ora and welcome to Pharmacy Today Kaitiaki Rongo O Te W Not a subscriber
Notably, EGCG administered via diet was well tolerated and demonstrated reduced hepatotoxicity compared to gavage administration in animals (233)
To ensure temporality between GLP-1 RA use and SUD onset, we established the observation window from January 1, 2005 (the year of initial GLP-1 RA approval) to February 24, 2025, based on the most recent data available from the AoU dataset
however, in early November 2025, the FDA indicated that supply of brand Victoza is limited due to delayed shipping
Furthermore, glutathione's ability to prevent melanin formation can help reduce hyperpigmentation, black spots, and uneven skin tone, resulting in a brighter, more even complexion
Potential benefits of combining intermittent fasting and GLP-1 medications Pairing intermittent fasting with GLP-1 medications may offer several synergistic benefits: Enhanced weight loss: Both approaches reduce appetite and calorie intake, potentially leading to faster and more sustainable weight loss